Implementing a clozapine supply service in Australian community pharmacies: barriers and facilitators

Table 5 Barriers reported by pharmacies not providing a clozapine supply service (n = 122)^a

Barriers to service implementation ^b	n	%
Lack of need for service (e.g. no clozapine consumers)	70	57.4
Limited knowledge of monitoring requirements	32	26.2
Clozapine has difficult supply arrangements	27	22.1
Limited financial return	25	20.5
Lack of time	23	18.9
Lack of access to training	22	18.0
Lack of external support or assistance	19	15.6
Increased resource requirements	18	14.8
Poor communication about regulatory changes	16	13.1
Difficulties in communication with prescribers	13	10.7
Do not believe clozapine should be supplied in the community	6	4.9
Other ^c	24	19.7

^a 122 respondents answered these questions; ^b Multiple responses allowed; ^c Other: included no information on how to implement the service, issues in implementing the service or unaware of the service